Dr. Moe Wehbe is a drug delivery scientist, entrepreneur, and platform builder with deep expertise in RNA therapeutics and lipid nanoparticle technology. He holds a Ph.D. in Pharmaceutical Sciences from the University of British Columbia.
Moe began his career in academic drug delivery research at UBC, where he co-invented a platform technology that became the foundation of Cuprous Pharmaceuticals, a UBC spinout. Following his postdoctoral training at Vanderbilt University, he served as a process development scientist at Recode Therapeutics and a founding scientist at Mirai Bio (Flagship Pioneering ecosystem), building and advancing extrahepatic LNP platforms from proof-of-concept through NHP-ready batches and GMP CDMO transfer.
Moe founded Moeda Consulting Corp. to make that depth available fractionally, to founders, VCs, and technology transfer offices who need it before they can justify a full-time hire.